(19)
(11) EP 2 651 885 A1

(12)

(43) Date of publication:
23.10.2013 Bulletin 2013/43

(21) Application number: 11806100.1

(22) Date of filing: 16.12.2011
(51) International Patent Classification (IPC): 
C07D 207/16(2006.01)
A61K 31/4025(2006.01)
A61K 31/4439(2006.01)
C07D 403/04(2006.01)
A61K 31/4184(2006.01)
A61P 31/12(2006.01)
(86) International application number:
PCT/US2011/065501
(87) International publication number:
WO 2012/083170 (21.06.2012 Gazette 2012/25)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 16.12.2010 US 423906 P

(71) Applicant: Abbvie Inc.
North Chicago, IL 60064 (US)

(72) Inventors:
  • KRUEGER, Allan, C.
    Gurnee Illinois 60031 (US)
  • KATI, Warren, M.
    Gurnee Illinois 60031 (US)
  • CARROLL, William, A.
    Evanston Illinois 60201 (US)
  • PRATT, John, K.
    Kenosha Wisconsin 53142 (US)
  • HUTCHINSON, Douglas, K.
    Newtown CT 06470-2787 (US)

(74) Representative: Modiano, Micaela Nadia 
Modiano & Partners (DE) Thierschstrasse 11
80538 München
80538 München (DE)

   


(54) ANTI-VIRAL COMPOUNDS